Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 Inhibition

Methods

Volumn 54, Issue 2, 2011, Pages 284-294

  Zhou, Jiehua ^a   Shu, Yi ^b   Guo, Peixuan ^b   Smith, David D ^c   Rossi, John J ^a,d  

^a Molecular and Cellular Biology City of Hope   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d City of Hope   (United States)

Author keywords

AIDS treatment; Anti gp120 aptamer; Bionanotechnology; Nanobiotechnology; Nanomotors; Nanotechnology; RNAi; Viral DNA packaging

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APTAMER; GLYCOPROTEIN GP 120; HYBRID PROTEIN; NANOPARTICLE; PRNA GP120 APTAMER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIOPHAGE; CHIMERA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; RNA STABILITY; TARGET CELL; VIRUS INHIBITION;

ANIMALS; APTAMERS, NUCLEOTIDE; BACILLUS PHAGES; CHO CELLS; CRICETINAE; CRICETULUS; HEK293 CELLS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; NANOPARTICLES; RIBONUCLEASE III; RNA INTERFERENCE; RNA STABILITY; RNA, SMALL INTERFERING; RNA, VIRAL;

BACILLUS PHAGE PHI29; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79958716788     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2010.12.039     Document Type: Article

References (48)

1. Richman D.D., Margolis D.M., Delaney M., Greene W.C., Hazuda D., Pomerantz R.J. Science 2009, 323:1304-1307.
2. Kim D.H., Rossi J.J. Nat. Rev. Genet. 2007, 8:173-184.
3. de Fougerolles A., Vornlocher H.P., Maraganore J., Lieberman J. Nat. Rev. Drug Discov. 2007, 6:443-453.
4. Rossi J.J., June C.H., Kohn D.B. Nat. Biotechnol. 2007, 25:1444-1454.
5. Scherer L., Rossi J.J., Weinberg M.S. Gene Ther. 2007, 14:1057-1064.
6. Subramanya S., Kim S.S., Manjunath N., Shankar P. Expert Opin. Biol. Ther. 2010, 10:201-213.
7. Kumar P., Ban H.S., Kim S.S., Wu H., Pearson T., Greiner D.L., Laouar A., Yao J., Haridas V., Habiro K., Yang Y.G., Jeong J.H., Lee K.Y., Kim Y.H., Kim S.W., Peipp M., Fey G.H., Manjunath N., Shultz L.D., Lee S.K., Shankar P. Cell 2008, 134:577-586.
8. Liu Z., Winters M., Holodniy M., Dai H. Angew. Chem. Int. Ed. Engl. 2007, 46:2023-2027.
9. Weber N., Ortega P., Clemente M.I., Shcharbin D., Bryszewska M., de la Mata F.J., Gomez R., Munoz-Fernandez M.A. J. Control. Release 2008, 132:55-64.
10. Eguchi A., Meade B.R., Chang Y.C., Fredrickson C.T., Willert K., Puri N., Dowdy S.F. Nat. Biotechnol. 2009, 27:567-571.
11. Castanotto D., Rossi J.J. Nature 2009, 457:426-433.
12. Whitehead K.A., Langer R., Anderson D.G. Nat. Rev. Drug Discov. 2009, 8:129-138.
13. Guo P. Nat. Nanotechnol. 2010, 5:833-842.
14. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. Nature 1984, 312:763-767.
15. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., Montagnier L. Nature 1984, 312:767-768.
16. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Nature 1998, 393:648-659.
17. Ugolini S., Mondor I., Sattentau Q.J. Trends Microbiol. 1999, 7:144-149.
18. Wyatt R., Sodroski J. Science 1998, 280:1884-1888.
19. Chan D.C., Kim P.S. Cell 1998, 93:681-684.
20. Blair W.S., Lin P.F., Meanwell N.A., Wallace O.B. Drug Discov. Today 2000, 5:183-194.
21. Moore J.P., Doms W. Proc. Natl Acad. Sci. USA 2003, 100:10598-10602.
22. Zhou J., Li H., Li S., Zaia J., Rossi J.J. Mol. Ther. 2008, 16:1481-1489.
23. Zhou J., Swiderski P., Li H., Zhang J., Neff C.P., Akkina R., Rossi J.J. Nucleic Acids Res. 2009.
24. Guo P., Zhang C., Chen C., Garver K., Trottier M. Mol. Cell 1998, 2:149-155.
25. Guo P.X., Erickson S., Anderson D. Science 1987, 236:690-694.
26. Hoeprich S., Guo P. J. Biol. Chem. 2002, 277:20794-20803.
27. Shu D., Huang L.P., Hoeprich S., Guo P. J. Nanosci. Nanotechnol. 2003, 3:295-302.
28. Khaled A., Guo S., Li F., Guo P. Nano Lett. 2005, 5:1797-1808.
29. Shu D., Moll W.D., Deng Z., Mao C., Guo P. Nano Lett. 2004, 4:1717-1723.
30. Guo P. J. Nanosci. Nanotechnol. 2005, 5:1964-1982.
31. Guo S., Tschammer N., Mohammed S., Guo P. Hum. Gene Ther. 2005, 16:1097-1109.
32. Li L., Liu J., Diao Z., Shu D., Guo P., Shen G. Mol. BioSyst. 2009, 5:1361-1368.
33. Liu J., Guo S., Cinier M., Shlyakhtenko L.S., Shu Y., Chen C., Shen G., Guo P. ACS Nano 2010.
34. Weiss C.D., White J.M. J. Virol. 1993, 67:7060-7066.
35. Vodicka M.A., Goh W.C., Wu L.I., Rogel M.E., Bartz S.R., Schweickart V.L., Raport C.J., Emerman M. Virology 1997, 233:193-198.
36. Reid R.J., Bodley J.W., Anderson D. J. Biol. Chem. 1994, 269:5157-5162.
37. Reid R.J., Zhang F., Benson S., Anderson D. J. Biol. Chem. 1994, 269:18656-18661.
38. Chen C., Sheng S., Shao Z., Guo P. J. Biol. Chem. 2000, 275:17510-17516.
39. Garver K., Guo P. RNA 1997, 3:1068-1079.
40. Zhang C., Lee C.S., Guo P. Virology 1994, 201:77-85.
41. Chen C., Zhang C., Guo P. RNA 1999, 5:805-818.
42. Zhang C., Tellinghuisen T., Guo P. RNA 1997, 3:315-323.
43. Khati M., Schuman M., Ibrahim J., Sattentau Q., Gordon S., James W. J. Virol. 2003, 77:12692-12698.
44. Dey A.K., Khati M., Tang M., Wyatt R., Lea S.M., James W. J. Virol. 2005, 79:13806-13810.
45. Cohen C., Forzan M., Sproat B., Pantophlet R., McGowan I., Burton D., James W. Virology 2008, 381:46-54.
46. Kim D.H., Behlke M.A., Rose S.D., Chang M.S., Choi S., Rossi J.J. Nat. Biotechnol. 2005, 23:222-226.
47. Guo S., Huang F., Guo P. Gene Ther. 2006, 13:814-820.
48. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Nature 1998, 391:806-811.